TRPC4 inactivation confers a survival benefit in severe pulmonary arterial hypertension

American Journal of Pathology

Volumn 183, Issue 6, 2013, Pages 1779-1788

  Alzoubi, Abdallah ^a,b   Almalouf, Philip ^b   Toba, Michie ^b,d   O'Neill, Kealan ^b   Qian, Xun ^c   Francis, Michael ^c   Taylor, Mark S ^c   Alexeyev, Mikhail ^b,c   McMurtry, Ivan F ^b   Oka, Masahiko ^b   Stevens, Troy ^b  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH ALABAMA   (United States)

^d JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SEMAXANIB; TRANSIENT RECEPTOR POTENTIAL CHANNEL 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FISCHER 344 RAT; HEART OUTPUT; HEART RIGHT VENTRICLE FAILURE; HEMODYNAMIC PARAMETERS; HYPOXIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PULMONARY ARTERY OCCLUSION; PULMONARY HYPERTENSION; RAT; SURVIVAL; VASCULAR LESION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CARDIAC OUTPUT; DISEASE MODELS, ANIMAL; HYPERTENSION, PULMONARY; INDOLES; MALE; PULMONARY ARTERY; PYRROLES; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRPC CATION CHANNELS;

EID: 84888242422     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.08.016     Document Type: Article

References (49)

1. G. Simonneau, I.M. Robbins, M. Beghetti, R.N. Channick, M. Delcroix, C.P. Denton, C.G. Elliott, S.P. Gaine, M.T. Gladwin, Z.C. Jing, M.J. Krowka, D. Langleben, N. Nakanishi, and R. Souza Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 1 Suppl 2009 S43 S54
2. S.Y. Chan, and J. Loscalzo Pathogenic mechanisms of pulmonary arterial hypertension J Mol Cell Cardiol 44 2008 14 30
3. N.W. Morrell, S. Adnot, S.L. Archer, J. Dupuis, P.L. Jones, M.R. MacLean, I.F. McMurtry, K.R. Stenmark, P.A. Thistlethwaite, N. Weissmann, J.X. Yuan, and E.K. Weir Cellular and molecular basis of pulmonary arterial hypertension J Am Coll Cardiol 54 1 Suppl 2009 S20 S31
4. V.V. McLaughlin, K.W. Presberg, R.L. Doyle, S.H. Abman, D.C. McCrory, T. Fortin, and G. Ahearn Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines Chest 126 1 Suppl 2004 78S 92S
5. O. Sitbon, M. Humbert, X. Jaïs, V. Ioos, A.M. Hamid, S. Provencher, G. Garcia, F. Parent, P. Hervé, and G. Simonneau Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension Circulation 111 2005 3105 3111
6. R.L. Benza, D.P. Miller, R.J. Barst, D.B. Badesch, A.E. Frost, and M.D. McGoon An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry Chest 142 2012 448 456
7. M.J. Berridge, M.D. Bootman, and H.L. Roderick Calcium signalling: dynamics, homeostasis and remodelling Nat Rev Mol Cell Biol 4 2003 517 529
8. C.V. Remillard, and J.X. Yuan High altitude pulmonary hypertension: role of K+ and Ca2+ channels High Alt Med Biol 6 2005 133 146
9. M.Y. Song, A. Makino, and J.X. Yuan STIM2 contributes to enhanced store-operated Ca entry in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension Pulm Circ 1 2011 84 94
10. A. Makino, A.L. Firth, and J.X. Yuan Endothelial and smooth muscle cell ion channels in pulmonary vasoconstriction and vascular remodeling Compr Physiol 1 2011 1555 1602
11. S. Zhang, C.V. Remillard, I. Fantozzi, and J.X. Yuan ATP-induced mitogenesis is mediated by cyclic AMP response element-binding protein-enhanced TRPC4 expression and activity in human pulmonary artery smooth muscle cells Am J Physiol Cell Physiol 287 2004 C1192 C1201
12. A.L. Firth, C.V. Remillard, O. Platoshyn, I. Fantozzi, E.A. Ko, and J.X. Yuan Functional ion channels in human pulmonary artery smooth muscle cells: voltage-dependent cation channels Pulm Circ 1 2011 48 71
13. M.J. Lin, G.P. Leung, W.M. Zhang, X.R. Yang, K.P. Yip, C.M. Tse, and J.S. Sham Chronic hypoxia-induced upregulation of store-operated and receptor-operated Ca2+ channels in pulmonary arterial smooth muscle cells: a novel mechanism of hypoxic pulmonary hypertension Circ Res 95 2004 496 505
14. A. Dietrich, H. Kalwa, B. Fuchs, F. Grimminger, N. Weissmann, and T. Gudermann In vivo TRPC functions in the cardiopulmonary vasculature Cell Calcium 42 2007 233 244
15. D.L. Cioffi, S. Wu, M. Alexeyev, S.R. Goodman, M.X. Zhu, and T. Stevens Activation of the endothelial store-operated ISOC Ca2+ channel requires interaction of protein 4.1 with TRPC4 Circ Res 97 2005 1164 1172
16. K.D. Phelan, M.M. Mock, O. Kretz, U.T. Shwe, M. Kozhemyakin, L.J. Greenfield, A. Dietrich, L. Birnbaumer, M. Freichel, V. Flockerzi, and F. Zheng Heteromeric canonical transient receptor potential 1 and 4 channels play a critical role in epileptiform burst firing and seizure-induced neurodegeneration Mol Pharmacol 81 2012 384 392
17. A.J. Baines, P.M. Bennett, E.W. Carter, and C. Terracciano Protein 4.1 and the control of ion channels Blood Cells Mol Dis 42 2009 211 215
18. K.T. Cheng, H.L. Ong, X. Liu, and I.S. Ambudkar Contribution of TRPC1 and Orai1 to Ca(2+) entry activated by store depletion Adv Exp Med Biol 704 2011 435 449
19. M. Potier, J.C. Gonzalez, R.K. Motiani, I.F. Abdullaev, J.M. Bisaillon, H.A. Singer, and M. Trebak Evidence for STIM1- and Orai1-dependent store-operated calcium influx through ICRAC in vascular smooth muscle cells: role in proliferation and migration FASEB J 23 2009 2425 2437
20. D.L. Cioffi, C. Barry, and T. Stevens Store-operated calcium entry channels in pulmonary endothelium: the emerging story of TRPCS and Orai1 Adv Exp Med Biol 661 2010 137 154
21. F. Lantoine, L. Iouzalen, M.A. Devynck, E. Millanvoye-Van Brussel, and M. David-Dufilho Nitric oxide production in human endothelial cells stimulated by histamine requires Ca2+ influx Biochem J 330 1998 695 699
22. M. Freichel, S.H. Suh, A. Pfeifer, U. Schweig, C. Trost, P. Weissgerber, M. Biel, S. Philipp, D. Freise, G. Droogmans, F. Hofmann, V. Flockerzi, and B. Nilius Lack of an endothelial store-operated Ca2+ current impairs agonist-dependent vasorelaxation in TRP4-/- mice Nat Cell Biol 3 2001 121 127
23. C. Tiruppathi, M. Freichel, S.M. Vogel, B.C. Paria, D. Mehta, V. Flockerzi, and A.B. Malik Impairment of store-operated Ca2+ entry in TRPC4(-/-) mice interferes with increase in lung microvascular permeability Circ Res 91 2002 70 76
24. P. Cinelli, A. Rettich, B. Seifert, K. Bürki, and M. Arras Comparative analysis and physiological impact of different tissue biopsy methodologies used for the genotyping of laboratory mice Lab Anim 41 2007 174 184
25. M. Francis, X. Qian, C. Charbel, J. Ledoux, J.C. Parker, and M.S. Taylor Automated region of interest analysis of dynamic Ca(2+) signals in image sequences Am J Physiol Cell Physiol 303 2012 C236 C243
26. M.S. Taylor, M. Francis, X. Qian, and V. Solodushko Dynamic Ca(2+) signal modalities in the vascular endothelium Microcirculation 19 2012 423 429
27. L.G. Rudski, W.W. Lai, J. Afilalo, L. Hua, M.D. Handschumacher, K. Chandrasekaran, S.D. Solomon, E.K. Louie, and N.B. Schiller Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography J Am Soc Echocardiogr 23 2010 685 713 quiz 786-688
28. M. Oka, V. Karoor, N. Homma, T. Nagaoka, E. Sakao, S.M. Golembeski, J. Limbird, M. Imamura, S.A. Gebb, K.A. Fagan, and I.F. McMurtry Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension Cardiovasc Res 74 2007 377 387
29. D. Heath, and J.E. Edwards The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects Circulation 18 1958 533 547
30. K. Abe, M. Toba, A. Alzoubi, M. Ito, K.A. Fagan, C.D. Cool, N.F. Voelkel, I.F. McMurtry, and M. Oka Formation of plexiform lesions in experimental severe pulmonary arterial hypertension Circulation 121 2010 2747 2754
31. D.G. Welsh, A.D. Morielli, M.T. Nelson, and J.E. Brayden Transient receptor potential channels regulate myogenic tone of resistance arteries Circ Res 90 2002 248 250
32. H.J. Bogaard, K. Abe, A. Vonk Noordegraaf, and N.F. Voelkel The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension Chest 135 2009 794 804
33. R.D. Machado, M.A. Aldred, V. James, R.E. Harrison, B. Patel, E.C. Schwalbe, E. Gruenig, B. Janssen, R. Koehler, W. Seeger, O. Eickelberg, H. Olschewski, C.G. Elliott, E. Glissmeyer, J. Carlquist, M. Kim, A. Torbicki, A. Fijalkowska, G. Szewczyk, J. Parma, M.J. Abramowicz, N. Galie, H. Morisaki, S. Kyotani, N. Nakanishi, T. Morisaki, M. Humbert, G. Simonneau, O. Sitbon, F. Soubrier, F. Coulet, N.W. Morrell, and R.C. Trembath Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension Hum Mutat 27 2006 121 132
34. J.R. Thomson, R.D. Machado, M.W. Pauciulo, N.V. Morgan, M. Humbert, G.C. Elliott, K. Ward, M. Yacoub, G. Mikhail, P. Rogers, J. Newman, L. Wheeler, T. Higenbottam, J.S. Gibbs, J. Egan, A. Crozier, A. Peacock, R. Allcock, P. Corris, J.E. Loyd, R.C. Trembath, and W.C. Nichols Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family J Med Genet 37 2000 741 745
35. J. Gomez-Arroyo, S.J. Saleem, S. Mizuno, A.A. Syed, H.J. Bogaard, A. Abbate, L. Taraseviciene-Stewart, Y. Sung, D. Kraskauskas, D. Farkas, D.H. Conrad, M.R. Nicolls, and N.F. Voelkel A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects Am J Physiol Lung Cell Mol Physiol 302 2012 L977 L991
36. L. Taraseviciene-Stewart, Y. Kasahara, L. Alger, P. Hirth, G. Mc Mahon, J. Waltenberger, N.F. Voelkel, and R.M. Tuder Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension FASEB J 15 2001 427 438
37. J. Cozzi, A. Fraichard, and K. Thiam Use of genetically modified rat models for translational medicine Drug Discov Today 13 2008 488 494
38. A. Macchia, R. Marchioli, R. Marfisi, M. Scarano, G. Levantesi, L. Tavazzi, and G. Tognoni A meta-analysis of trials of pulmonary hypertension: a clinical condition looking for drugs and research methodology Am Heart J 153 2007 1037 1047
39. E.K. Weir, H.L. Reeve, D.A. Peterson, E.D. Michelakis, D.P. Nelson, and S.L. Archer Pulmonary vasoconstriction, oxygen sensing, and the role of ion channels: Thomas A. Neff lecture Chest 114 1 Suppl 1998 17S 22S
40. E. Stacher, B.B. Graham, J.M. Hunt, A. Gandjeva, S.D. Groshong, V.V. McLaughlin, M. Jessup, W.E. Grizzle, M.A. Aldred, C.D. Cool, and R.M. Tuder Modern age pathology of pulmonary arterial hypertension Am J Respir Crit Care Med 186 2012 261 272
41. R. Bowers, C. Cool, R.C. Murphy, R.M. Tuder, M.W. Hopken, S.C. Flores, and N.F. Voelkel Oxidative stress in severe pulmonary hypertension Am J Respir Crit Care Med 169 2004 764 769
42. H.J. Bogaard, A. Al Husseini, L. Farkas, D. Farkas, J. Gomez-Arroyo, A. Abbate, and N.F. Voelkel Severe pulmonary hypertension: the role of metabolic and endocrine disorders Pulm Circ 2 2012 148 154
43. H. El Chami, and P.M. Hassoun Immune and inflammatory mechanisms in pulmonary arterial hypertension Prog Cardiovasc Dis 55 2012 218 228
44. 2+ signaling Am J Physiol Heart Circ Physiol 302 2012 H1546 H1562
45. L. Piao, G. Marsboom, and S.L. Archer Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure J Mol Med (Berl) 88 2010 1011 1020
46. M. Oka, N. Homma, L. Taraseviciene-Stewart, K.G. Morris, D. Kraskauskas, N. Burns, N.F. Voelkel, and I.F. McMurtry Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats Circ Res 100 2007 923 929
47. M.J. Berridge Calcium signalling and cell proliferation Bioessays 17 1995 491 500
48. S. Rich, J. Pogoriler, A.N. Husain, P.T. Toth, M. Gomberg-Maitland, and S.L. Archer Long-term effects of epoprostenol on the pulmonary vasculature in idiopathic pulmonary arterial hypertension Chest 138 2010 1234 1239
49. A. Alzoubi, M. Toba, K. Abe, K.D. O'Neill, P. Rocic, K.A. Fagan, I.F. McMurtry, and M. Oka Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension Am J Physiol Heart Circ Physiol 304 2013 H1708 H1718